Interpretation of biomonitoring data in clinical medicine and the exposure sciences

Bryan L. Williams, Dana B. Barr, J. Michael Wright, Brian Buckley, Melina S. Magsumbol

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Biomonitoring has become a fundamental tool in both exposure science and clinical medicine. Despite significant analytical advances, the clinical use of environmental biomarkers remains in its infancy. Clinical use of environmental biomarkers poses some complex scientific and ethical challenges. The purpose of this paper is compare how the clinical and exposure sciences differ with respect to their interpretation and use of biological data. Additionally, the clinical use of environmental biomonitoring data is discussed. A case study is used to illustrate the complexities of conducting biomonitoring research on highly vulnerable populations in a clinical setting.

Original languageEnglish (US)
Pages (from-to)76-80
Number of pages5
JournalToxicology and Applied Pharmacology
Issue number1
StatePublished - Nov 15 2008


  • Biomarkers
  • Biomonitoring
  • Clinical medicine
  • Exposure science
  • Lead
  • Mercury
  • Neonatal exposures
  • Susceptible populations

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology


Dive into the research topics of 'Interpretation of biomonitoring data in clinical medicine and the exposure sciences'. Together they form a unique fingerprint.

Cite this